Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos.

PURPOSE To extract quantitative perfusion and texture features with computer assistance from contrast-enhanced ultrasound (CEUS) videos of breast cancer before and after neoadjuvant chemotherapy (NAC), and to evaluate pathologic response to NAC with these features. METHODS Forty-two CEUS videos with 140,484 images were acquired from 21 breast cancer patients pre- and post-NAC. Time-intensity curve (TIC) features were calculated including the difference between area under TIC within a tumor and that within a computer-detected reference region (AUT_T-R). Four texture features were extracted including Homogeneity and Contrast. All patients were identified as pathologic responders by Miller and Payne criteria. The features between pre- and post-treatment in these responders were statistically compared, and the discrimination between pre- and post-treatment cancers was assessed with a receiver operating characteristic (ROC) curve. RESULTS Compared with the pre-treatment cancers, the post-treatment cancers had significantly lower Homogeneity (p<0.001) and AUT_T-R (p=0.014), as well as higher Contrast (p<0.001), indicating the intratumoral contrast enhancement decreased and became more heterogeneous after NAC in responders. The combination of Homogeneity and AUT_T-R achieved an accuracy of 90.5% and area under ROC curve of 0.946 for discrimination between pre- and post-chemotherapy cancers without cross validation. The accuracy still reached as high as 85.7% under leave-one-out cross validation. CONCLUSIONS The computer-extracted CEUS features show reduced and more heterogeneous neovascularization of cancer after NAC. The features achieve high accuracy for discriminating between pre- and post-chemotherapy cancers in responders and thus are potentially valuable for tumor response evaluation in clinical practice.

[1]  Charles Tremblay-Darveau,et al.  Dynamic contrast enhanced ultrasound for therapy monitoring. , 2015, European journal of radiology.

[2]  Quing Zhu,et al.  Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography. , 2013, Radiology.

[3]  Wei Qian,et al.  Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy. , 2015, Medical physics.

[4]  Giovanna Rizzo,et al.  Characterization of cervical lymph-nodes using a multi-parametric and multi-modal approach for an early prediction of tumor response to chemo-radiotherapy. , 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[5]  D. Noh,et al.  Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival. , 2016, Radiology.

[6]  Ying Lu,et al.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. , 2002, AJR. American journal of roentgenology.

[7]  Jianwen Luo,et al.  A fast normalized cross-correlation calculation method for motion estimation , 2010, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[8]  Qi Zhang,et al.  Deep learning based classification of breast tumors with shear-wave elastography. , 2016, Ultrasonics.

[9]  Martin J. Yaffe,et al.  Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture , 2014, Oncotarget.

[10]  Bin Zhao,et al.  Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer. , 2012, Ultrasound in medicine & biology.

[11]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[12]  H. Junkermann,et al.  Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy , 2003, European Radiology.

[13]  Thierry Metens,et al.  Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy , 2016, European Radiology.

[14]  S. Krishnamurthy,et al.  MRI features of inflammatory breast cancer. , 2011, AJR. American journal of roentgenology.

[15]  J. Gornbein,et al.  Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy , 2009, Cancer.

[16]  N. Thacker,et al.  Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.

[17]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[18]  Y Wang,et al.  Spatio-temporal Quantification of Carotid Plaque Neovascularization on Contrast Enhanced Ultrasound: Correlation with Visual Grading and Histopathology. , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  Purang Abolmaesumi,et al.  Ultrasound RF Time Series for Classification of Breast Lesions , 2015, IEEE Transactions on Medical Imaging.

[20]  Reinhold Muller,et al.  Dynamic Contrast‐Enhanced Ultrasound for Quantification of Tissue Perfusion , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  D A Clevert,et al.  Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study. , 2007, World journal of gastroenterology.

[22]  Mark A. Helvie,et al.  Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy , 2005, Breast Cancer Research and Treatment.

[23]  J. Ahn,et al.  Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI , 2007, Acta oncologica.

[24]  Eun Sook Ko,et al.  Breast cancer heterogeneity: MR Imaging Texture Analysis and Survival Outcomes1 , 2016 .

[25]  Peter Gibbs,et al.  Texture analysis in assessment and prediction of chemotherapy response in breast cancer , 2013, Journal of magnetic resonance imaging : JMRI.

[26]  Lijing Yang,et al.  Computer-aided quantification of contrast agent spatial distribution within atherosclerotic plaque in contrast-enhanced ultrasound image sequences , 2014, Biomed. Signal Process. Control..

[27]  Ji-Bin Liu,et al.  Contrast‐Enhanced Breast Ultrasonography , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[28]  A. Hutcheon,et al.  A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. , 2003, Breast.

[29]  K. Ding,et al.  Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model. , 2015, Medical physics.

[30]  P. Bartlett,et al.  Probabilities for SV Machines , 2000 .

[31]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.

[32]  Vicky Goh,et al.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.